Shalby Limited (BOM:540797)
153.05
-1.65 (-1.07%)
At close: Aug 21, 2026
Shalby Revenue
Shalby had revenue of 3.31B INR in the quarter ending June 30, 2026, with 11.74% growth. This brings the company's revenue in the last twelve months to 11.76B, up 6.50% year-over-year. In the fiscal year ending March 31, 2026, Shalby had annual revenue of 11.41B with 5.01% growth.
Revenue (ttm)
11.76B
Revenue Growth
+6.50%
P/S Ratio
1.40
Revenue / Employee
4.54M
Employees
2,592
Market Cap
16.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 11.41B | 544.75M | 5.01% |
| Mar 31, 2025 | 10.87B | 1.53B | 16.41% |
| Mar 31, 2024 | 9.34B | 1.29B | 16.00% |
| Mar 31, 2023 | 8.05B | 1.06B | 15.16% |
| Mar 31, 2022 | 6.99B | 2.68B | 62.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SpiceJet | 47.86B |
| SMC Global Securities | 16.55B |
| Media Matrix Worldwide | 14.52B |
| Blue Cloud Softech Solutions | 10.89B |
| Mahanagar Telephone Nigam | 10.01B |
| Virtuoso Optoelectronics | 9.96B |
| DISA India | 4.25B |
| Titan Biotech | 2.20B |
Shalby News
- 5 months ago - Shalby inaugurates oncology department with advanced radiotherapy in Surat hospital - Business Upturn
- 1 year ago - Shalby signs MoU with Bhartiya Skill Development University to launch B.Voc programs in healthcare - Business Upturn
- 1 year ago - Shalby shares drop over 2% as Q1 net profit falls 43% YoY to Rs 8.9 crore, Ebitda down 8% YoY - Business Upturn
- 1 year ago - Shalby shares drop 4% as EBITDA falls 20.1% YoY in Q3 - Business Upturn
- 1 year ago - Shalby shares jump 3% after FDA approval for Duraniom knee replacement device - Business Upturn